Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population.

ABSTRACT:

Background

Hepatitis C virus (HCV) treatment regimens (DAAs) are well tolerated, efficacious but costly. Their high cost and restricted availability, raises concerns about the outcome of treatment in uninsured patients. This study investigated sustained virologic response (SVR) outcomes in a predominately uninsured patient population and completion of four steps along the HCV treatment cascade.

Methods

A retrospective chart review was conducted to characterize the patient population and analyze covariates to determine association with insurance status, attainment of SVR and progression through the HCV treatment cascade.

Results

Out of a total of 216 patients, 154 (71%) were uninsured. Approximately 50% of patients (109 of 216 patients) were male and 57% were Hispanic

SUBMITTER: DeBose-Scarlett A 

PROVIDER: S-EPMC6027772 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature